High Court Won't Review Inequitable Conduct Standards
The U.S. Supreme Court on Monday denied Apotex Inc.'s bid for the first-ever review of the standard for proving inequitable conduct in patent cases, declining to hear the drug manufacturer's appeal...To view the full article, register now.
Already a subscriber? Click here to view full article